The demographic characteristics of the patients were. molecular tests for use in primary healthcare settings, have also become available recently. Alere shares were down more than 7 percent to 36.92 in afternoon trading on the New York Stock Exchange, while Abbott shares were down a fraction of a percent at 38.38. The samples were transported in 3 mL of viral transport medium (VTM) for immediate molecular diagnosis. Check with your local representative for availability in specific markets. Alere said it will take all actions necessary to protect its shareholders and to compel Abbott to complete the transaction in accordance with its terms. Not all products are available in all regions. GDPR Statement | Declaration for California Compliance Law. Any person depicted in such photographs is a model. We are committed to developing tests capable of putting invaluable answers in the hands of clinicians and caregivers around the world. The company offers its services to molecular diagnostic laboratories, government laboratories, academic institutions, hospitals, genomic research centers. (U.S.), a diagnostic device manufacturer and service provider, which Abbott acquired in October 2017. Photos displayed are for illustrative purposes only. Our point-of-care diagnostics are focused on the world’s most critical health needs including cardiology, infectious disease, toxicology, traumatic brain injury, and more. The Rapid Diagnostics business is a part of Alere Inc. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. a They may be reagents, techniques, instruments, or a combination of these used in vitro for the examination of specimens such as blood, urine or tissue with the goal of obtaining a diagnosis from assays in a controlled environment outside a living organism.
#ALERE MOLECULAR DIAGNOSTICS REGISTRATION#
The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. Generally speaking in vitro diagnostics (IVD) tests are considered medical devices. This website is governed by applicable U.S. Efforts are expected to further improve sensitivity and user-friendliness for effective and widespread use in the true point-of-care setting. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. The Alere i Influenza A & B assay provides a rapid and simple platform for detection and differentiation of Flu A and B. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
0 kommentar(er)
